Skip to main content
TipRanks
Go Ultimate75% OFF

Sun Pharma Advanced Research Co. Ltd. (SPARC) Stock Statistics & Valuation Metrics

8 Followers

Total Valuation

Sun Pharma Advanced Research Co. Ltd. has a market cap or net worth of INR 62.71B. The enterprise value is INR 51.04B.

Market Cap
INR 62.71B
Enterprise Value
INR 51.04B

Share Statistics

Sun Pharma Advanced Research Co. Ltd. has 324,521,600 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
324,521,600
Owned by Insiders
―
Owned by Institutions
2.06%

Financial Efficiency

Sun Pharma Advanced Research Co. Ltd.’s return on equity (ROE) is 1.16 and return on invested capital (ROIC) is 80.40%.

Return on Equity (ROE)
1.16
Return on Assets (ROA)
0.72
Return on Invested Capital (ROIC)
80.40%
Return on Capital Employed (ROCE)
1.12
Revenue Per Employee
67.35M
Profits Per Employee
55.67M
Employee Count
279
Asset Turnover
0.87
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Sun Pharma Advanced Research Co. Ltd. is 3.83. Sun Pharma Advanced Research Co. Ltd.’s PEG ratio is 0.01.

PE Ratio
3.83
PS Ratio
3.25
PB Ratio
4.36
Price to FCF
0.00
Price to Operating Cash Flow
0.00
PEG Ratio
0.01

Income Statement

In the last 12 months, Sun Pharma Advanced Research Co. Ltd. had revenue of 18.79B and earned 15.53B in profits. Earnings per share was 47.86.

Revenue
18.79B
Gross Profit
17.27B
Operating Income
15.89B
Pretax Income
15.53B
Net Income
15.53B
EBITDA
15.99B
Earnings Per Share (EPS)
47.86

Cash Flow

In the last 12 months, operating cash flow was -1.16B and capital expenditures -231.40M, giving a free cash flow of -1.39B billion.

Operating Cash Flow
-1.16B
Free Cash Flow
-1.39B
Free Cash Flow per Share
0.00

Dividends & Yields

Sun Pharma Advanced Research Co. Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
0.00%
Earnings Yield
26.03%

Stock Price Statistics

Beta
1.75
52-Week Price Change
46.85%
50-Day Moving Average
192.87
200-Day Moving Average
182.65
Relative Strength Index (RSI)
50.20
Average Volume (3m)
105.69K

Important Dates

Sun Pharma Advanced Research Co. Ltd. upcoming earnings date is Feb 15, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 02, 2026
Next Earnings Date
Feb 15, 2027
Ex-Dividend Date
―

Financial Position

Sun Pharma Advanced Research Co. Ltd. as a current ratio of 2.47, with Debt / Equity ratio of 41.78%

Current Ratio
2.47
Quick Ratio
2.47
Debt to Market Cap
0.15
Net Debt to EBITDA
0.35
Interest Coverage Ratio
46.54

Taxes

In the past 12 months, Sun Pharma Advanced Research Co. Ltd. has paid -1.90M in taxes.

Income Tax
-1.90M
Effective Tax Rate
-0.00

Enterprise Valuation

Sun Pharma Advanced Research Co. Ltd. EV to EBITDA ratio is 3.16, with an EV/FCF ratio of 0.00.

EV to Sales
2.70
EV to EBITDA
3.16
EV to Free Cash Flow
0.00
EV to Operating Cash Flow
0.00

Balance Sheet

Sun Pharma Advanced Research Co. Ltd. has INR 11.55M in cash and marketable securities with INR 0.00 in debt, giving a net cash position of INR 11.55M billion.

Cash & Marketable Securities
INR 11.55M
Total Debt
INR 0.00
Net Cash
INR 11.55M
Net Cash Per Share
INR 0.04
Tangible Book Value Per Share
INR 41.26

Margins

Gross margin is 93.10%, with operating margin of 84.26%, and net profit margin of 84.68%.

Gross Margin
93.10%
Operating Margin
84.26%
Pretax Margin
84.68%
Net Profit Margin
84.68%
EBITDA Margin
85.33%
EBIT Margin
84.84%

Analyst Forecast

The average price target for Sun Pharma Advanced Research Co. Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
3140.97%
EPS Growth Forecast
―

Scores

Smart Score
―
AI Score
50